Colgate-Palmolive (NYSE:CL) Shares Acquired by Natixis Advisors LLC

Natixis Advisors LLC lifted its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 15.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 386,681 shares of the company's stock after purchasing an additional 51,991 shares during the quarter. Natixis Advisors LLC's holdings in Colgate-Palmolive were worth $40,141,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. purchased a new position in Colgate-Palmolive in the 2nd quarter worth approximately $25,000. Continuum Advisory LLC boosted its holdings in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after buying an additional 125 shares during the period. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the 3rd quarter worth $53,000. Finally, Gradient Investments LLC boosted its holdings in Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock worth $65,000 after buying an additional 400 shares during the period. 80.41% of the stock is owned by institutional investors.

Insider Activity

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. The trade was a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.34% of the company's stock.

Colgate-Palmolive Stock Up 1.2 %

Shares of NYSE CL traded up $1.09 during midday trading on Monday, reaching $94.65. 4,487,695 shares of the company's stock traded hands, compared to its average volume of 4,388,260. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock's 50 day simple moving average is $99.31 and its 200-day simple moving average is $98.54. Colgate-Palmolive has a one year low of $75.17 and a one year high of $109.30. The company has a market cap of $77.33 billion, a price-to-earnings ratio of 26.81, a P/E/G ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive's dividend payout ratio is presently 57.31%.

Wall Street Analyst Weigh In

Several research firms have commented on CL. HSBC reissued a "hold" rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. Barclays increased their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an "equal weight" rating in a report on Monday, July 29th. Hsbc Global Res lowered shares of Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 26th. Finally, Piper Sandler initiated coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.